文献速递慢阻肺

慢阻肺患者与健康对照者的下呼吸道微生物群比较

Lower airway microbiota in COPD and healthy controls.
PubMed 文献 · Thorax · 2024-02-08

MicroCOPD 研究对 97 例慢阻肺患者和 97 名对照者的保护性支气管肺泡灌洗液进行测序,发现慢阻肺患者下呼吸道微生物群丰富度与对照相当,但均匀度更低;厚壁菌门某些属在慢阻肺气道中富集;吸烟对微生物群的影响在慢阻肺与对照中不同,而疾病严重程度和吸入糖皮质激素使用与微生物群无关。

要点

  • 慢阻肺患者下呼吸道微生物群均匀度低于健康对照。
  • 厚壁菌门部分属在慢阻肺气道中富集。
  • 吸烟对微生物群的影响在慢阻肺与对照中不同。

核心结论

  • 慢阻肺患者下呼吸道微生物群丰富度与对照相当但均匀度更低,厚壁菌门某些属在慢阻肺气道中富集。

研究设计与样本

  • MicroCOPD 研究为单中心研究,2012 至 2015 年纳入 97 例慢阻肺患者和 97 名对照者。
  • 获取保护性支气管肺泡灌洗样本,采用 Illumina MiSeq 系统双端测序,数据用 QIIME 2 和 R 分析。

主要发现

  • α多样性在慢阻肺患者低于对照:Pielou 均匀度慢阻肺=0.76、对照=0.80,p=0.004;Shannon 熵慢阻肺=3.98、对照=4.34,p=0.01。
  • β多样性仅在慢阻肺队列中随吸烟状态不同:加权 UniFrac 置换方差分析 R2=0.04,p=0.03。
  • 慢阻肺与对照之间有 9 个属的丰度存在差异,慢阻肺中富集的属属于厚壁菌门。
  • 仅在对照中,包年与某些类群丰度差异相关:Haemophilus 对数倍数差异 -0.05/q=0.048;Lachnoanaerobaculum -0.04/q=0.03。
  • 吸烟慢阻肺患者中 Oribacterium 缺失,与非吸烟患者相比 ANCOM-BC 对数倍数差异 -1.46/q=0.03。

临床怎么用

  • 解读慢阻肺患者下呼吸道微生物群时需考虑均匀度下降及厚壁菌门属富集。
  • 吸烟对微生物群的影响在慢阻肺与健康人群中可能不同,评估时应区分人群。

局限性

  • 单中心研究,结果外推需谨慎。
  • 未发现微生物群与慢阻肺严重程度或吸入糖皮质激素使用相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The lower airway microbiota in patients with chronic obstructive pulmonary disease (COPD) are likely altered compared with the microbiota in healthy individuals. Information on how the microbiota is affected by smoking, use of inhaled corticosteroids (ICS) and COPD severity is still scarce. METHODS: In the MicroCOPD Study, participant characteristics were obtained through standardised questionnaires and clinical measurements at a single centre from 2012 to 2015. Protected bronchoalveolar lavage samples from 97 patients with COPD and 97 controls were paired-end sequenced with the Illumina MiSeq System. Data were analysed in QIIME 2 and R. RESULTS: Alpha-diversity was lower in patients with COPD than controls (Pielou evenness: COPD=0.76, control=0.80, p=0.004; Shannon entropy: COPD=3.98, control=4.34, p=0.01). Beta-diversity differed with smoking only in the COPD cohort (weighted UniFrac: permutational analysis of variance R2=0.04, p=0.03). Nine genera were differentially abundant between COPD and controls. Genera enriched in COPD belonged to the Firmicutes phylum. Pack years were linked to differential abundance of taxa in controls only (ANCOM-BC (Analysis of Compositions of Microbiomes with Bias Correction) log-fold difference/q-values: Haemophilus -0.05/0.048; Lachnoanaerobaculum -0.04/0.03). Oribacterium was absent in smoking patients with COPD compared with non-smoking patients (ANCOM-BC log-fold difference/q-values: -1.46/0.03). We found no associations between the microbiota and COPD severity or ICS. CONCLUSION: The lower airway microbiota is equal in richness in patients with COPD to controls, but less even. Genera from the Firmicutes phylum thrive particularly in COPD airways. Smoking has different effects on diversity and taxonomic abundance in patients with COPD compared with controls. COPD severity and ICS use were not linked to the lower airway microbiota.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Tangedal S, Nielsen R, Aanerud M, et al. Lower airway microbiota in COPD and healthy controls. Thorax. 2024. PMID: 38331579. doi:10.1136/thorax-2023-220455

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。